Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics

:1 24–35 24 © 2006 Eli Lilly and Company Correspondence S. T. Forgue, Lilly Corporate Center DC0734, Indianapolis, IN 46285, USA. Tel: + 1 317 277 7991 Fax: + 1 317 433 6661 E-mail: in the UK, Belgium, Poland and Germany in healthy male and female subjects, elderlys.t.forgue@lilly.com Keywords erectile dysfunction, pharmacokinetics, phosphodiesterase, tadalafilB.E.P. present address: Novartis Horsham Research Centre, Horsham, West Sussex, UK. Received 31 October 2005 Accepted 26 April 2006 Published